BioAge Labs, Inc. was founded based on the idea that aging is a major risk factor for many diseases, including Alzheimer’s disease, diabetes, cancer and cardiovascular disease, so the company set out to learn about and target fundamental mechanisms of aging with compounds discovered internally or in-licensed from external sources.
“We believe that by better understanding aging biology, we'll discover important new targets to help treat disease,” CEO Kristen Fortney explained in an interview with Scrip
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?